Tezacaftor is a type of drug known as a cystic fibrosis transmembrane conductance regulator (CFTR) corrector.
This means Tezacaftor belongs to a class of medications specifically designed to treat cystic fibrosis (CF). CFTR correctors work by helping the defective CFTR protein, which causes cystic fibrosis, to fold properly and reach the cell surface. A properly functioning CFTR protein is crucial for regulating the flow of salt and water in and out of cells in the lungs and other organs. By improving the function of this protein, CFTR correctors help to alleviate some of the symptoms of cystic fibrosis.
